Top compounds associated with response to MT-ND2


Feature Type Standardized
Nominal ANOVA
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.1 0.007
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.008
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.095 0.009
mRNA etoposide CTRPv2 pan-cancer AAC -0.083 0.009
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.01
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.01
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.01
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.11 0.01
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.13 0.01
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.097 0.01
Download CSV